- Home
- / ReShape Lifesciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ReShape Lifesciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.9
2024-10-29
Market Capitalization
$3 M
2024-10-29
Revenue
$11.3 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 311.5K | 292.0K | 786.7K | 1.3M | 606.7K | 15.1M | 11.3M | |||
| Revenue growth, % | -6.3% | 169.4% | ||||||||
| Cost of goods sold | 231.5K | 125.0K | 431.5K | 936.4K | 164.3K | 5.8M | 5.0M | |||
| Gross profit | 80.0K | 167.0K | 355.2K | 350.8K | 442.4K | 9.3M | 6.3M | |||
| Gross profit margin, % | 25.7% | 57.2% | 45.2% | 27.3% | 72.9% | 61.7% | 55.4% | |||
| General and administrative expense | 8.6M | 12.0M | 13.7M | 14.6M | 19.9M | 18.0M | 26.0M | 19.3M | 4.8M | 4.7M |
| Operating expense total | 25.3M | 22.6M | 24.7M | 25.6M | 28.0M | 23.2M | 31.8M | 39.0M | 33.8M | 18.7M |
| EBIT | (22.5M) | (24.7M) | (25.6M) | (27.9M) | (22.8M) | (31.4M) | (38.5M) | (24.5M) | (12.5M) | |
| EBIT margin, % | -7239.0% | -9543.4% | -2897.8% | -2440.1% | -6353.3% | -162.1% | -110.2% | |||
| Interest income | 12.2K | 9.9K | 5.7K | 3.3K | 1.8K | 5.8K | 1.1K | |||
| Interest expense | 722.9K | 901.8K | 4.1M | |||||||
| Pre tax profit | (36.1M) | (38.7M) | (75.1M) | (21.8M) | ||||||
| Income tax expense | (2.3M) | (3.4M) | (893.0K) | (181.0K) | ||||||
| Net Income | (26.0M) | (23.5M) | (25.8M) | (26.1M) | (25.5M) | (23.4M) | (33.8M) | (81.2M) | (74.2M) | (21.6M) |